Literature DB >> 24664876

Diagnostic Exome Sequencing and Tailored Bioinformatics of the Parents of a Deceased Child with Cobalamin Deficiency Suggests Digenic Inheritance of the MTR and LMBRD1 Genes.

Kelly D Farwell Gonzalez1, Xiang Li, Hsiao-Mei Lu, Hong Lu, Joan E Pellegrino, Ryan T Miller, Wenqi Zeng, Elizabeth C Chao.   

Abstract

Disorders of cobalamin deficiency are a heterogeneous group of disorders with at least 19 autosomal recessive-associated genes. Familial samples of an infant who died due to presumed cobalamin deficiency were referred for clinical exome sequencing. The patient died before obtaining a blood sample or skin biopsy, autopsy was declined, and DNA yielded from the newborn screening blood spot was insufficient for diagnostic testing. Whole-exome sequencing of the mother, father, and unaffected sister and tailored bioinformatics analysis was applied to search for mutations in underlying disorders with recessive inheritance. This approach identified alterations within two genes, each of which was carried by one parent. The mother carried a missense alteration in the MTR gene (c.3518C>T; p.P1173L) which was absent in the father and the sister. The father carried a translational frameshift alteration in the LMBRD1 gene (c.1056delG; p.L352Lfs*18) which was absent in the mother and present in the heterozygous state in the sister. These mutations in the MTR (MIM# 156570) and LMBRD1 (MIM# 612625) genes have been described in patients with disorders of cobalamin metabolism complementation groups cblG and cblF, respectively. The child's clinical presentation and biochemical results demonstrated overlap with both cblG and cblF. Sanger sequencing using DNA from the infant's blood spot confirmed the inheritance of the two alterations in compound heterozygous form. We present the first example of exome sequencing leading to a diagnosis in the absence of the affected patient. Furthermore, the data support the possibility for potential digenic inheritance associated with cobalamin deficiency.

Entities:  

Year:  2014        PMID: 24664876      PMCID: PMC4270861          DOI: 10.1007/8904_2014_294

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  35 in total

1.  dbSNP: the NCBI database of genetic variation.

Authors:  S T Sherry; M H Ward; M Kholodov; J Baker; L Phan; E M Smigielski; K Sirotkin
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

Review 2.  Insights into lysosomal cobalamin trafficking: lessons learned from cblF disease.

Authors:  Susann Gailus; Wolfgang Höhne; Bruno Gasnier; Peter Nürnberg; Brian Fowler; Frank Rutsch
Journal:  J Mol Med (Berl)       Date:  2010-02-20       Impact factor: 4.599

3.  Novel splice site mutations and a large deletion in three patients with the cblF inborn error of vitamin B12 metabolism.

Authors:  Isabelle R Miousse; David Watkins; David S Rosenblatt
Journal:  Mol Genet Metab       Date:  2011-01-14       Impact factor: 4.797

4.  Defects in human methionine synthase in cblG patients.

Authors:  S Gulati; P Baker; Y N Li; B Fowler; W Kruger; L C Brody; R Banerjee
Journal:  Hum Mol Genet       Date:  1996-12       Impact factor: 6.150

Review 5.  National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000.

Authors: 
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

6.  Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B12 metabolism.

Authors:  Frank Rutsch; Susann Gailus; Isabelle R Miousse; Terttu Suormala; Corinne Sagné; Mohammad Reza Toliat; Gudrun Nürnberg; Tanja Wittkampf; Insa Buers; Azita Sharifi; Martin Stucki; Christian Becker; Matthias Baumgartner; Horst Robenek; Thorsten Marquardt; Wolfgang Höhne; Bruno Gasnier; David S Rosenblatt; Brian Fowler; Peter Nürnberg
Journal:  Nat Genet       Date:  2009-01-11       Impact factor: 38.330

7.  Mutations in ABCD4 cause a new inborn error of vitamin B12 metabolism.

Authors:  David Coelho; Jaeseung C Kim; Isabelle R Miousse; Stephen Fung; Marcel du Moulin; Insa Buers; Terttu Suormala; Patricie Burda; Michele Frapolli; Martin Stucki; Peter Nürnberg; Holger Thiele; Horst Robenek; Wolfgang Höhne; Nicola Longo; Marzia Pasquali; Eugen Mengel; David Watkins; Eric A Shoubridge; Jacek Majewski; David S Rosenblatt; Brian Fowler; Frank Rutsch; Matthias R Baumgartner
Journal:  Nat Genet       Date:  2012-08-26       Impact factor: 38.330

8.  Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing.

Authors:  Andreas Gnirke; Alexandre Melnikov; Jared Maguire; Peter Rogov; Emily M LeProust; William Brockman; Timothy Fennell; Georgia Giannoukos; Sheila Fisher; Carsten Russ; Stacey Gabriel; David B Jaffe; Eric S Lander; Chad Nusbaum
Journal:  Nat Biotechnol       Date:  2009-02-01       Impact factor: 54.908

9.  The Human Gene Mutation Database: 2008 update.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Howells; Andrew D Phillips; Nick St Thomas; David N Cooper
Journal:  Genome Med       Date:  2009-01-22       Impact factor: 11.117

10.  Lifting the lid on unborn lethal Mendelian phenotypes through exome sequencing.

Authors:  Hanan E Shamseldin; Abdulrahman Swaid; Fowzan S Alkuraya
Journal:  Genet Med       Date:  2012-10-04       Impact factor: 8.822

View more
  6 in total

Review 1.  BRAT1 mutations present with a spectrum of clinical severity.

Authors:  Siddharth Srivastava; Heather E Olson; Julie S Cohen; Cynthia S Gubbels; Sharyn Lincoln; Brigette Tippin Davis; Layla Shahmirzadi; Siddharth Gupta; Jonathan Picker; Timothy W Yu; David T Miller; Janet S Soul; Andrea Poretti; SakkuBai Naidu
Journal:  Am J Med Genet A       Date:  2016-06-09       Impact factor: 2.802

2.  Diagnostic Exome Sequencing Identifies a Novel Gene, EMILIN1, Associated with Autosomal-Dominant Hereditary Connective Tissue Disease.

Authors:  Alessandra Capuano; Francesco Bucciotti; Kelly D Farwell; Brigette Tippin Davis; Cameron Mroske; Peter J Hulick; Scott M Weissman; Qingshen Gao; Paola Spessotto; Alfonso Colombatti; Roberto Doliana
Journal:  Hum Mutat       Date:  2015-11-04       Impact factor: 4.878

3.  Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.

Authors:  Holly LaDuca; Kelly D Farwell; Huy Vuong; Hsiao-Mei Lu; Wenbo Mu; Layla Shahmirzadi; Sha Tang; Jefferey Chen; Shruti Bhide; Elizabeth C Chao
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

4.  Clinical diagnostic exome evaluation for an infant with a lethal disorder: genetic diagnosis of TARP syndrome and expansion of the phenotype in a patient with a newly reported RBM10 alteration.

Authors:  Zöe Powis; Alexa Hart; Sara Cherny; Igor Petrik; Erika Palmaer; Sha Tang; Carolyn Jones
Journal:  BMC Med Genet       Date:  2017-06-02       Impact factor: 2.103

5.  Diagnostic exome sequencing identifies GLI2 haploinsufficiency and chromosome 20 uniparental disomy in a patient with developmental anomalies.

Authors:  Samin A Sajan; Zöe Powis; Katherine L Helbig; Honey Nagakura; Ladonna Immken; Sha Tang; Wendy A Alcaraz
Journal:  Clin Case Rep       Date:  2018-05-08

6.  A New, Atypical Case of Cobalamin F Disorder Diagnosed by Whole Exome Sequencing.

Authors:  Panayiotis Constantinou; Mariella D'Alessandro; Paul Lochhead; Shalaka Samant; W Michael Bisset; Catherine Hauptfleisch; John Dean
Journal:  Mol Syndromol       Date:  2015-10-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.